Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Barbara De Moerloose

Awards & Distinctions

Results : ALL ( 9 )

As Promotor-spokesperson

01 October 2023 → 30 September 2027

Research assignment of Prof. dr. Tim Lammens, framing the ongoing clinical-translational research at the Department of Pediatric Hematology-Oncology and Stem Cell Transplantation

Funding: Funding by bilateral agreement (private and foundations)

As Promotor

01 January 2015 → 31 December 2018

Evaluation of the prognostic value of the leukemic stem cell (LSC) and pre-leukemic hematopoietic stem cell (pre-L HSC) for minimal residual disease monitoring and clinical management of pediatric acute myeloid leukemia patients

Fellows: Tim Lammens

Funding: Funding by bilateral agreement (private and foundations)

01 January 2023 → 31 December 2026

Integration of genome, epigenome, and transcriptome in juvenile myelomonocytic leukemia and functional analysis of circular RNAs as novel biomarker and/or therapeutic targets

Funding: Funding by bilateral agreement (private and foundations)

01 October 2020 → 30 September 2021

Long non-coding RNAs as therapeutic targets in acute myeloid leukemia

Funding: Funding by bilateral agreement (private and foundations)

01 January 2013 → 31 December 2015

The role of non-coding RNA in juvenile myelomonocytic leukemia

Funding: Funding by bilateral agreement (private and foundations)

15 December 2012 → 31 December 2013

The role of non-coding RNA in juvenile myelomonocytic leukemia

Funding: Funding by bilateral agreement (private and foundations)

01 January 2024 → 31 December 2025

Translational research in the field of hematological malignancies in children

Funding: Regional and community funding: Special Research Fund

As Copromotor

01 November 2024 → 31 October 2028

Multi-Omics Profiling in Juvenile Myelomonocytic Leukemia: Unveiling Pathobiology for Refined Patient Management.

Fellow: Jolien De Waele

Funding: Research Foundation - Flanders (FWO)

01 October 2021 → 30 September 2024

Preclinical evaluation of newly identified therapeutic targets in pediatric acute myeloid leukemia

Funding: Funding by bilateral agreement (private and foundations)